Myelodysplastic Syndromes (MDS) Event Free Survival With Iron Chelation Therapy Study
Public ClinicalTrials.gov record NCT00940602. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multi-center, Randomized, Double-blind, Placebo-controlled Clinical Trial of Deferasirox in Patients With Myelodysplastic Syndromes (Low/Int-1 Risk) and Transfusional Iron Overload
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This was a randomized, double-blind trial to evaluate deferasirox vs placebo in patients with myelodysplastic syndromes (low/int-1 risk) and transfusional iron overload .The trial was conducted in 17 countries, started in 2010 and ended in 2018.
Study identification
- NCT ID
- NCT00940602
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 225 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 21, 2010
- Primary completion
- Feb 26, 2018
- Completion
- Feb 26, 2018
- Last update posted
- Nov 22, 2020
2010 – 2018
United States locations
- U.S. sites
- 11
- U.S. states
- 9
- U.S. cities
- 11
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Pacific Cancer Medical Center, Inc. PAC Center | Anaheim | California | 92801 | — |
| Rocky Mountain Cancer Centers RMCC | Greenwood Village | Colorado | — | — |
| Willis-Knighton Cancer Center Dept of Onc | Shreveport | Louisiana | 71103 | — |
| Henry Ford Hospital Henry Ford | Detroit | Michigan | 48202 | — |
| Midwest Cancer Care Physicians MMCC | Kansas City | Missouri | 64131 | — |
| Mercy Medical Research Institute SC | Manchester | Missouri | 63021 | — |
| Glacier View Research Institute - Cancer SC | Kalispell | Montana | 59901 | — |
| Hackensack University Medical Center Department of Research | Hackensack | New Jersey | 07601 | — |
| University of Texas MD Anderson Cancer Center Dept of MD Anderson (16) | Houston | Texas | 77030 | — |
| Cancer Care Centers of South Texas HOAST CCC of So.TX- MedicalCenter(2) | San Antonio | Texas | 78229 | — |
| Swedish Cancer Institute Ballard Campus | Seattle | Washington | 98107 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 60 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00940602, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 22, 2020 · Synced Sep 1, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00940602 live on ClinicalTrials.gov.